Josephine M. Forbes

21.3k total citations · 3 hit papers
205 papers, 16.0k citations indexed

About

Josephine M. Forbes is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Josephine M. Forbes has authored 205 papers receiving a total of 16.0k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Clinical Biochemistry, 70 papers in Endocrinology, Diabetes and Metabolism and 59 papers in Nephrology. Recurrent topics in Josephine M. Forbes's work include Advanced Glycation End Products research (107 papers), Chronic Kidney Disease and Diabetes (51 papers) and Natural Antidiabetic Agents Studies (25 papers). Josephine M. Forbes is often cited by papers focused on Advanced Glycation End Products research (107 papers), Chronic Kidney Disease and Diabetes (51 papers) and Natural Antidiabetic Agents Studies (25 papers). Josephine M. Forbes collaborates with scholars based in Australia, United States and Germany. Josephine M. Forbes's co-authors include Mark E. Cooper, Melinda T. Coughlan, Merlin C. Thomas, David R. Thorburn, Wendy C. Burns, Vicki Thallas, Vicki Thallas‐Bonke, Karly C. Sourris, Sally A. Penfold and George Jerums and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Josephine M. Forbes

203 papers receiving 15.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanisms of Diabetic Complications

2013 2.1k citations Josephine M. Forbes, Mark E. Cooper profile →
Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes

2008 987 citations Josephine M. Forbes, Melinda T. Coughlan et al. profile →
Mitochondrial dysfunction in diabetic kidney disease

2018 452 citations Josephine M. Forbes et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Josephine M. Forbes Australia	64	5.6k	5.3k	4.2k	3.2k	2.5k	205	16.0k
Angelika Bierhaus Germany	74	10.1k 1.8×	4.1k 0.8×	6.2k 1.5×	1.8k 0.6×	3.3k 1.3×	247	22.7k
Casper G. Schalkwijk Netherlands	77	6.3k 1.1×	5.9k 1.1×	4.1k 1.0×	2.0k 0.6×	4.0k 1.6×	483	21.5k
Sho‐ichi Yamagishi Japan	80	10.3k 1.8×	7.8k 1.5×	6.0k 1.4×	2.4k 0.8×	3.8k 1.5×	449	23.2k
Daisuke Koya Japan	75	2.4k 0.4×	4.1k 0.8×	6.6k 1.6×	4.1k 1.3×	3.6k 1.4×	292	18.9k
Masayoshi Takeuchi Japan	62	7.3k 1.3×	5.0k 0.9×	2.8k 0.7×	1.3k 0.4×	1.8k 0.7×	256	12.4k
Shi Fang Yan United States	59	8.5k 1.5×	3.5k 0.7×	3.8k 0.9×	853 0.3×	2.8k 1.1×	105	14.1k
Rama Natarajan United States	79	1.7k 0.3×	2.8k 0.5×	10.0k 2.4×	2.0k 0.6×	2.2k 0.9×	246	18.5k
Vincent M. Monnier United States	68	10.2k 1.8×	5.1k 1.0×	4.7k 1.1×	1.2k 0.4×	4.2k 1.7×	209	17.2k
Erwin Schleicher Germany	57	2.6k 0.5×	2.4k 0.4×	4.7k 1.1×	823 0.3×	2.9k 1.1×	203	12.0k
Michael Brownlee United States	58	10.6k 1.9×	10.5k 2.0×	9.7k 2.3×	2.4k 0.7×	8.5k 3.4×	106	35.1k

Countries citing papers authored by Josephine M. Forbes

Since Specialization

Citations

This map shows the geographic impact of Josephine M. Forbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josephine M. Forbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josephine M. Forbes more than expected).

Fields of papers citing papers by Josephine M. Forbes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josephine M. Forbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josephine M. Forbes. The network helps show where Josephine M. Forbes may publish in the future.

Co-authorship network of co-authors of Josephine M. Forbes

This figure shows the co-authorship network connecting the top 25 collaborators of Josephine M. Forbes. A scholar is included among the top collaborators of Josephine M. Forbes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josephine M. Forbes. Josephine M. Forbes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nag, Purba, Xiangju Wang, Seokchan Hong, et al.. (2025). Human proximal tubular epithelial cell interleukin-1 receptor signalling triggers G2/M arrest and cellular senescence during hypoxic kidney injury. Cell Death and Disease. 16(1). 61–61. 3 indexed citations

Laakso, E‐Liisa, et al.. (2025). Efficacy and Safety of Photobiomodulation in MELAS: Protocol for a Series of N-of-1 Trials. Journal of Clinical Medicine. 14(6). 2047–2047.

Leung, Sherman S., Nataliya Lenchik, Clayton E. Mathews, et al.. (2023). Alpha cell receptor for advanced glycation end products associate with glucagon expression in type 1 diabetes. Scientific Reports. 13(1). 12948–12948. 4 indexed citations

Chen, Chen, et al.. (2022). Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development. Cells. 11(21). 3503–3503. 30 indexed citations

Flemming, Nicole, et al.. (2022). Mitochondrial Dysfunction in Individuals with Diabetic Kidney Disease: A Systematic Review. Cells. 11(16). 2481–2481. 17 indexed citations

Zhuang, Aowen, Felicia Y. T. Yap, Clinton R. Bruce, et al.. (2017). Increased liver AGEs induce hepatic injury mediated through an OST48 pathway. Scientific Reports. 7(1). 12292–12292. 22 indexed citations

Gallo, Linda A., Micheal Ward, Amelia K. Fotheringham, et al.. (2016). Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice. Scientific Reports. 6(1). 26428–26428. 126 indexed citations

Borg, Danielle J., Sherman S. Leung, Aowen Zhuang, et al.. (2015). Delivery of recombinant human soluble receptor for advanced glycation end products delays autoimmune diabetes in the NOD mouse model. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations

Tesch, Greg H., Karly C. Sourris, Shaun A. Summers, et al.. (2014). Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes. Diabetologia. 57(9). 1977–1985. 26 indexed citations

10.

Zhuang, Aowen, Brooke E. Harcourt, Amelia K. Fotheringham, et al.. (2014). Ager1 overexpression in glomerular podocytes results in renal disease which is exacerbated by diabetes. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations

11.

Tesch, Greg H., Scott A. Summers, D M McCarthy, et al.. (2014). Deficiency of rage in bone marrow cells reduces renal injury in diabetic mice. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations

12.

Thallas‐Bonke, Vicki, Jay C. Jha, Stephen P. Gray, et al.. (2014). Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy. Physiological Reports. 2(11). e12192–e12192. 87 indexed citations

13.

Forbes, Josephine M., David C.H. Harris, & Mark E. Cooper. (2013). Report on ISN Forefronts, Melbourne, Australia, 4–7 October 2012: tubulointerstitial disease in diabetic nephropathy. Kidney International. 84(4). 653–656. 3 indexed citations

14.

Forbes, Josephine M., Jenny Söderlund, Felicia Y. T. Yap, et al.. (2011). Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia. 54(5). 1032–1042. 39 indexed citations

15.

Sourris, Karly C., Brooke E. Harcourt, Sally A. Penfold, et al.. (2010). Modulation of the Cellular Expression of Circulating Advanced Glycation End-Product Receptors in Type 2 Diabetic Nephropathy. Experimental Diabetes Research. 2010. 1–9. 18 indexed citations

16.

Thomas, Merlin C. & Josephine M. Forbes. (2010). The Maillard reaction : interface between aging, nutrition and metabolism. 20 indexed citations

17.

Norman, Paul E., Wendy A. Davis, Melinda T. Coughlan, et al.. (2009). Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men Study. Journal of Vascular Surgery. 50(3). 626–631. 12 indexed citations

18.

Forbes, Josephine M., Vicki Thallas‐Bonke, Mark E. Cooper, & Merlin C. Thomas. (2004). Advanced Glycation: How are we Progressing to Combat this Web of Sugar Anomalies in Diabetic Nephropathy. Current Pharmaceutical Design. 10(27). 3361–3372. 10 indexed citations

19.

Tikellis, Chris, C. I. Johnston, Josephine M. Forbes, et al.. (2004). Identification of angiotensin converting enzyme 2 in the rodent retina. Current Eye Research. 29(6). 419–427. 66 indexed citations

20.

Forbes, Josephine M., et al.. (2003). Reversible Angiotensin II-Mediated Albuminuria in Rat Kidneys Is Dynamically Associated with Cytoskeletal Organization. Nephron Physiology. 93(2). p51–p60. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact